Search for: "KING PHARMACEUTICALS, INC." Results 1 - 20 of 212
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Aug 2010, 9:57 pm by Patent Docs
By Andrew Williams -- Last week, in King Pharmaceuticals, Inc. v. [read post]
25 Nov 2008, 5:01 am
By Jason Derry -- King Pharmaceuticals, Inc. has announced that it will purchase Alpharma Inc. for about $1.6 billion in cash. [read post]
King Pharmaceuticals, Inc., King Pharmaceuticals (which was acquired by Pfizer in 2010) restrained trade in violation of the Tennessee Trade Practices Act and common law by entering into a reverse-payment agreement in 2005 with Mutual Pharmaceutical Company. [read post]
19 Nov 2008, 5:52 am
By Kwame Mensah -- Last month, King Pharmaceuticals, Inc. announced that it is extending its previously announced tender offer for all outstanding shares of Class A Common Stock of Alpharma Inc. [read post]
12 Aug 2010, 5:45 pm by Dennis Crouch
[Read the full essay] On August 2, 2010, the Federal Circuit affirmed the district court’s summary judgment of patent invalidity in King Pharmaceuticals, Inc. v. [read post]
26 Nov 2007, 9:02 pm
By Baltazar Gomez -- Last month, Astellas Pharma Inc., King Pharmaceuticals, Inc., and Teva Pharmaceutical Industries Ltd. announced that U.S. subsidiaries of Astellas, along with Item Development AB and King have signed settlement agreements with respect to U.S. [read post]
16 Mar 2010, 11:32 am by Ben Vernia
The Department of Justice announced on March 16 that Alpharma, Inc., a subsidiary of Bristol, Tennessee-based King Pharmaceuticals, Inc., has paid $42.5 million to settle allegations brought by a whistleblower that it paid health care professionals to prescribe its morphine-derived drug, Kadian. [read post]
4 Nov 2009, 9:28 pm
On Nov. 2, King Pharmaceuticals, Inc., Monarch Pharmaceuticals, Inc., King Pharmaceuticals Research and Development, Inc., and Gentrac, Inc., filed suit against Seattle-based ZymoGenetics, Inc., in the Eastern District of Tennessee. [read post]
23 Feb 2009, 9:59 pm
By Suresh Pillai --King Pharmaceuticals' Patents on SKELAXIN ® Invalidated By District Court In the case of King Pharmaceuticals, Inc. v. [read post]
7 Sep 2009, 9:34 pm
King Pharmaceuticals Inc. et al. v. [read post]
22 Dec 2015, 9:00 am
The case was originally filed on June 10, 2003, by relators John King and Tammy Drummond, naming several pharmaceutical companies as defendants including Solvay Pharmaceuticals Inc. [read post]
22 Dec 2015, 9:00 am
The case was originally filed on June 10, 2003, by relators John King and Tammy Drummond, naming several pharmaceutical companies as defendants including Solvay Pharmaceuticals Inc. [read post]
22 Dec 2015, 9:00 am
The case was originally filed on June 10, 2003, by relators John King and Tammy Drummond, naming several pharmaceutical companies as defendants including Solvay Pharmaceuticals Inc. [read post]
28 Dec 2009, 5:29 pm
By Eric Goldman King Pharmaceuticals, Inc., v ZymoGenetics, Inc., 2009 WL 4931238 (E.D. [read post]
23 Jan 2011, 9:21 pm by Patent Docs
King Pharmaceuticals Inc. et al. v. [read post]
9 Oct 2011, 9:37 pm by Patent Docs
Watson Pharmaceuticals Inc. et al. 1:11-cv-00914; filed October 6, 2011 in the District Court of Delaware • Plaintiffs: Pfizer Inc.; Alpharma Pharmaceuticals LLC; King Pharmaceuticals Inc. [read post]
31 Dec 2008, 10:14 am
It took a few months, but--with help from lawyers at Dewey & LeBoeuf and Simpson Thacher--King Pharmaceuticals has completed its $1.6 billion acquisition of Alpharma, Inc. [read post]